Grail (GRAL) announced that patient-reported outcomes assessing patient perspectives from the PATHFINDER study were published in Lancet ...

GRAIL, Inc. (Nasdaq: GRAL) a healthcare company whose mission is to detect cancer early when it can be cured, today announced that patient-reported outcomes (PRO) assessing patient perspectives from ...

With video cameras in the ambulances, medical scientists can make today's stroke care even better for more patients. The same ...

Aggressive and misleading marketing is fuelling demand for medicinal cannabis. Here are some of the ways clinics bend the ...

The NHS says that when people are diagnosed with cancer they should undergo a holistic needs assessment. This involves ...

A decision to approve new medicines to treat Duchenne muscular dystrophy and a rare life-threatening blood disease for use in ...

The first human to contract a severe case of the current strain of bird flu has died, according to the Louisiana Department ...

Preliminary U.S. BRIUMVI fourth quarter and full year 2024 net product revenue of $103.6 million and $310 million, respectively. Full Year 2025 target total global revenue of appr ...

Companies are using AI that detects human emotions. People are upset but also getting wise by gaming AI on this. Here's the ...

Pathologic Complete Response reported for 2 patients with cutaneous Squamous Cell CarcinomaMarlborough, Massachusetts--(Newsfile Corp. - January ...

If you or a loved one is showing potential signs of age-related cognitive decline or dementia, you may want to seek help but not know the right type of health care provider to choose. That' ...

To start the year right, Fred Hutch scientists, providers and a patient advocate share tips to help readers keep up with the ...